Drug
Lansoprazole clinical trials
Also written Prevacid, Takepron and AG-1749.
- studies test it
- 91
- open now
- 4
- in phase 3
- 18
- first study started
- 2002
Keep track of what changes. Save the Lansoprazole studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Other names
Studies by the year they started
90 studies that test it; most in 2006 (12)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 5 |
| 2004 | 3 |
| 2005 | 7 |
| 2006 | 12 |
| 2007 | 6 |
| 2008 | 5 |
| 2009 | 6 |
| 2010 | 8 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 21
- Phase 2
- 11
- Phase 3
- 18
- Phase 4
- 33
- No phase
- 9
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 36 · Other 55
Takeda (12) · AstraZeneca (5) · Novartis (4) · National Taiwan University Hospital (4) · Teva Pharmaceuticals USA (3) · First Affiliated Hospital of Zhejiang University (2) · Mackay Memorial Hospital (2) · Neutec Ar-Ge San ve Tic A.Ş (2)
Often tested with
Tested in the same studies.
Amoxicillin (9) · Esomeprazole (7) · Clarithromycin (7) · Omeprazole (4) · Metronidazole (4) · Pantoprazole (3) · Vonoprazan (3) · Sitagliptin (2)
Studies
Open first, then newest update. How each study uses Lansoprazole is read from its arms, and is right about nine times in ten.
Testing it · 91
- Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.RecruitingNot applicableHualien Tzu Chi General HospitalNCT06778824Written as Takepron
- Treating People With Idiopathic Pulmonary Fibrosis With the Addition of LansoprazoleRecruitingPhase 3Norfolk and Norwich University Hospitals NHS Foundation TrustNCT04965298Written as Lansoprazole
- A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of ChileRecruitingNot applicableMiguel O'Ryan GallardoNCT05926804Written as Lansoprazole
- The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)Not yet recruitingPhase 4Daejeon St. Mary's hospitalNCT05820048Written as Lansoprazole 15 mg
- Effect of Obesity on Proton Pump InhibitorsCompletedPhase 4Children's Mercy Hospital Kansas CityNCT04248335Written as Lansoprazole
- Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux EsophagitisCompletedPhase 2Jiangsu Sinorda Biomedicine Co., LtdNCT04531475Written as Lansoprazole
- A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121CompletedPhase 1Addpharma Inc.NCT06025773Written as Lansoprazole 15 mg
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008CompletedPhase 1Jiangsu Carephar Pharmaceutical Co., Ltd.NCT05050188Written as Lansoprazole
- Medicine-induced Cardiac Hemodialysis on COVID-19CompletedPhase 4Yang I. PachankisNCT05711810Written as Lansoprazole 30Mg Ec Cap
- Cardiac Safety of Lansoprazole and Domperidon CombinationWithdrawnPhase 4Neutec Ar-Ge San ve Tic A.ŞNCT03355170Written as Lansoprazole/Domperidone
- 13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)CompletedPhase 4Meridian Bioscience, Inc.NCT00825630Written as Lansoprazole (Lanton)
- The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast CancerCompletedPhase 3Tanta UniversityNCT04874935Written as Lansoprazole
- Effect of Proton Pump Inhibitors on Endothelial FunctionCompletedPhase 1Stanford UniversityNCT02022280Written as Lansoprazole
- Helicobacter Eradication Aspirin TrialCompletedPhase 4University of NottinghamNCT01506986Written as Lansoprazole 30mg, Clarithromycin 500mg, Metronidazole 400mg
- The Effects of Reducing Stomach Acid on Post-tonsillectomy PainTerminatedPhase 4Boston Children's HospitalNCT00472186Written as Lansoprazole
- Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori InfectionCompletedPhase 3TakedaNCT03050307Written as Lansoprazole
- Response to Oral Lansoprazole of Inorganic Pyrophosphate Levels in Patients With Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum)Status unknownPhase 4Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludNCT04660461Written as Lansoprazole 30mg
- Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori InfectionCompletedPhase 3TakedaNCT03050359Written as Lansoprazole
- PPI Therapy Impact on GERD After Sleeve GastrectomyStatus unknownEarly Phase 1University of Roma La SapienzaNCT04400136Written as Lansoprazole oral tablets 30 mg
- AZD4635 Relative Bioavailability StudyCompletedPhase 1AstraZenecaNCT03710434Written as Lansoprazole and AZD4635 50 mg solid oral formulation
See all 91 studies that test Lansoprazole →
Given in every arm · 20 — Lansoprazole is usual care beside what is tested
- The Effect of Vitamin D Supplement as Adjuvant Therapy in Eradication of Helicobacter Pylori InfectionNot yet recruitingPhase 3Assiut UniversityNCT06964334Written as Lansoprazole
- A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With LansoprazoleCompletedPhase 2Cinclus Pharma Holding ABNCT05055128Written as Lansoprazole
- A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerWithdrawnPhase 2The Christie NHS Foundation TrustNCT04188119Written as Lansoprazole
- Helicobacter Pylori Eradication StudyCompletedPhase 4Inje UniversityNCT03130452Written as Lansoprazole 30mg
- A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT04453189Written as Lansoprazole
- Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 PatientsCompletedPhase 3RAAS Nutritionals, LLCNCT05417997Written as Lansoprazole
- Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine CancerCompletedPhase 2University Hospital, GhentNCT03192059Written as Lansoprazole
- Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive EsophagitisCompletedPhase 3TakedaNCT02388737Written as Lansoprazole
- A Study of LY2940680 in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT01681186Written as Lansoprazole
- A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerWithdrawnPhase 2The Christie NHS Foundation TrustNCT03794596Written as Lansoprazole (Proton Pump Inhibitor)
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male SubjectsCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT03487562Written as Lansoprazole
- Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple TherapyCompletedPhase 4Xijing Hospital of Digestive DiseasesNCT02633930Written as Lansoprazole
- Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With GoutCompletedPhase 3TakedaNCT02139046Written as Lansoprazole
- Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal ImpairmentCompletedPhase 2TakedaNCT02128490Written as Lansoprazole
- A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux EsophagitisCompletedPhase 4YongChan LeeNCT02755753Written as Lansoprazole
- High Dose Amoxicillin Versus Tetracycline as Second-line Treatment of Resistant Helicobacter Pylori InfectionCompletedPhase 4Shanghai Jiao Tong University School of MedicineNCT02175927Written as Lansoprazole
- Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori EradicationCompletedPhase 4Shanghai Jiao Tong University School of MedicineNCT02175901Written as Lansoprazole
- Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pHCompletedPhase 4Boehringer IngelheimNCT02251184Written as Lansoprazole
- Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori TreatmentCompletedPhase 4Shanghai Jiao Tong University School of MedicineNCT01667718Written as Lansoprazole
- The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux DiseaseCompletedNot applicableSeoul National University HospitalNCT01039558Written as lansoprazole
As the comparator · 53 — what is tested is compared with Lansoprazole
- Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet TherapyRecruitingNot applicableSUK MIN SEONCT07479056Written as Lansoprazole 30mg
- Tegoprazan Versus Lansoprazole for Endoscopic Ulcer Healing in Bleeding Peptic UlcersRecruitingPhase 2Indonesia UniversityNCT07708545Written as Lansoprazole capsules
- Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive EsophagitisNot yet recruitingPhase 3Onconic Therapeutics Inc.NCT07732075Written as Lansoprazole 15mg
- Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric UlcerNot yet recruitingPhase 3Daewoong Pharmaceutical Co. LTD.NCT07730138Written as Lansoprazole 30mg
- Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic UlcerNot yet recruitingPhase 4Daewoong Pharmaceutical Co. LTD.NCT07533266Written as Lansoprazole 15 mg
- Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic UlcerRecruitingPhase 3Il-Yang Pharm. Co., Ltd.NCT06284876Written as Lansoprazole
- Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer TreatmentRecruitingNot applicableMario SteffanusNCT06894992Written as Lansoprazole
- A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)CompletedPhase 3Cinclus Pharma Holding ABNCT07037875Written as Lansoprazole 30 mg Once Daily (QD)
- Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDsCompletedPhase 3HK inno.N CorporationNCT04840550Written as Lansoprazole 15 mg
- Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential TherapyCompletedPhase 4Fu Jen Catholic University HospitalNCT06156085Written as Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole
- Efficacy of Fexuprazan for Prevention or Control of Gastritis Symptoms in Patients on Treatment With Systemic SteroidsCompletedPhase 4Yonsei UniversityNCT05946135Written as Lansoprazole
- The Phase III Clinical Trial of X842 Capsules for Reflux EsophagitisCompletedPhase 3Jiangsu Sinorda Biomedicine Co., LtdNCT07079540Written as Lansoprazole
- Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric UlcerCompletedPhase 3Onconic Therapeutics Inc.NCT05448001Written as Lansoprazole 30mg
- Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic UlcerCompletedPhase 3Daewoong Pharmaceutical Co. LTD.NCT04784910Written as Lansoprazole 15 mg
- Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term SafetyCompletedPhase 4TakedaNCT02679508Written as Lansoprazole
- Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among ChildrenCompletedPhase 2/3Finni KollinsNCT05861687Written as Lansoprazole
- Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal UlcerCompletedPhase 3Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.NCT05010954Written as Lansoprazole 30mg group
- Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan and Lansoprazole in Healthy ParticipantsCompletedPhase 1Phathom Pharmaceuticals, Inc.NCT04729101Written as Lansoprazole
- Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive EsophagitisCompletedPhase 3HK inno.N CorporationNCT04022096Written as Lansoprazole 15mg QD
- Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive EsophagitisCompletedPhase 3Phathom Pharmaceuticals, Inc.NCT04124926Written as Lansoprazole
Showing 20 of 53.
Codes
What other systems call Lansoprazole · ClinicalTrials.gg INT008976
- MeSH (NLM) D064747LansoprazoleConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 0K5C5T2QPGLANSOPRAZOLEConfirmed FDA, NLM, Wikidata
- RxNorm 17128Confirmed FDA, Wikidata
- Wikidata Q254296lansoprazoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29150LansoprazoleOne source FDA
- DrugBank DB00448One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D064747 | Lansoprazole | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 0K5C5T2QPG | LANSOPRAZOLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 17128 | — | Confirmed FDA, Wikidata |
| Wikidata | Q254296 | lansoprazole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29150 | Lansoprazole | One source FDA |
| DrugBank | DB00448 | — | One source Wikidata |
Also registered as lansoprazole sodium (UNII GV9NY1U369).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.